The market broke this stock on a narrative about 2028 and has not fully repaired it against an operating record that keeps improving.
Read Article ›At ~19x forward earnings on a franchise whose fee rate has inflected up after a decade of compression, with capital return stepping up and the two genuine risks slow-burning and priced into the downside case, BlackRock is worth owning through the volatility — not because it is...
Read Article ›The catalyst the market is under-weighting is the second derivative on organic billings: a steepening curve off a de-risked trough, with a bankrupt-tenant claim thrown in for free. The catalyst that broke this stock — the fiber write-downs, the dividend cut, the DISH default, ...
Read Article ›The discount as struck double-counts Argentina — once in the multiple and again in the reflex to distrust cash flows that are demonstrably Brent-linked and demonstrably deleveraging the balance sheet. The tape has earned back at least one of those two discounts.
Read Article ›Quanta is priced as a high-quality compounder rather than a bargain, and the near-term estimate momentum still points up as the raised guide and the un-booked corridor stacking feed the next several prints.
Read Article ›Dave is a genuinely compounding franchise with a data moat, temporarily mispriced because the market read a high-return reinvestment decision as margin decay, carrying a real and unreserved regulatory tail that justifies a discounted multiple but not the one the market assigne...
Read Article ›The hinge of the whole situation is a single line in the second-quarter results. Strip it out and clean 2026 earnings power sits closer to $15 a share — and 2027 then benefits a second time, because the refinancing itself lowers the ongoing interest bill.
Read Article ›The thesis lives in the hotels; the entertainment arm is a call option the market keeps trying to price and, I will argue, is getting wrong in a way that is more nuisance than opportunity.
Read Article ›The de-rating question the setup poses answers itself when you look closely: the stock is not down on a broken thesis but off its high in a broad healthcare drawdown, and the June quarter was a clean beat with a raise. So the honest verdict is not that McKesson is mispriced — ...
Read Article ›The central tension on AerCap — elite, scale-leading franchise versus a perennial, structurally-justified lessor discount — resolves, on the current evidence, in favor of the franchise.
Read Article ›At roughly 41x FY27E earnings against that growth and that balance sheet, Robinhood is mispriced as a crypto proxy when the crypto line has already fallen to 13% of revenue and the business kept compounding anyway. The market is underwriting the wrong risk, and the diversifica...
Read Article ›The reason to hold Costco through any multiple debate is that the membership line is not just growing — it is accelerating, and its quality is improving. Everyone agrees the franchise is elite. The contested question is whether 46x trailing earnings — roughly 40-42x forward — ...
Read Article ›The de-rating that took the stock from the high-$40s to $42 was a repricing of dividend reliability, not of asset quality — and the assets, the balance sheet and the well inventory are all in better shape now than when the stock was higher. At a high-single-digit cash yield wi...
Read Article ›Copart just delivered revenue growth, margin expansion, and higher EPS despite falling insurance volumes, backed by record pure-sale penetration, a rising total-loss frequency that structurally feeds its inventory, and a global bidder base that props up per-car economics.
Read Article ›The debate isn't whether URBN is a good business—it's whether the crowd re-rates it before the numbers force the issue. I think the setup into holiday, backed by buybacks and a conservatively built margin plan, tilts that resolution in shareholders' favor.
Read Article ›This is not a company watching solar demand evaporate; it is a premium hardware franchise re-routing US demand from cash sales onto TPO rails while monetizing a domestic-manufacturing credit annuity that peers can't match. The three things that decide the next two quarters are...
Read Article ›The market is trading this as a comp-recovery story, and the comp has recovered, but the actual swing factor for the next leg of the stock is margin, and specifically North America margin, which is still badly depressed.
Read Article ›L3Harris shares have retreated nearly 20% from their 52-week high near $379, creating a compelling entry into what is shaping up as a multi-year earnings inflection. A record $40.7 billion backlog—which management describes as approximately two times revenue coverage—means the...
Read Article ›TKO reported Q1 2026 revenue of $1.60 billion (+26% year-over-year) and Adjusted EBITDA of $550 million (+32%), with management reaffirming full-year guidance of $5.68–$5.78 billion in revenue and $2.24–$2.29 billion in Adjusted EBITDA. An $800 million accelerated share repurc...
Read Article ›S&P Global trades in the low $400s—roughly 21 times the midpoint of 2026 adjusted EPS guidance (~$19.50)—after falling nearly 29% from its August 2025 peak of $579. That valuation compression coincides with one of the stronger fundamental stretches in the company's history: 10...
Read Article ›